Kazuhiro Usui - Concepedia

Author

Kazuhiro Usui

NTT Medical Center ORCID

Also Known As

Ip, MSM, K USUI, K Usui, K. Usui, K. Usui Usui, K. Yoshimura, K., Usui, KAZUHIRO USUI, KOKI USUI, Kazuhiro USUI

163

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

NTT Medical Center Tohoku University Sendai Kousei Hospital Miyagi Prefectural Hospital Organization Institute of Aging

About

Kazuhiro Usui is an author at NTT Medical Center specializing in medicine, lung cancer, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	20	625
2	Health Sciences	5	5	134
3	Cell Biology	5	5	225
4	Engineering	2	2	26
5	Public Health	1	1	13

Kazuhiro Usui

Publications

Citations

H-Index

Page 1

	Year	Citations
First-Line Gefitinib for Patients With Advanced Non–Small-Cell Lung Cancer Harboring Epidermal Growth Factor Receptor Mutations Without Indication for Chemotherapy Akira Inoue, Kunihiko Kobayashi, Kazuhiro Usui, Journal of Clinical Oncology	2009	515
Proinflammatory Cytokine IL-1β Promotes Tumor Growth of Lewis Lung Carcinoma by Induction of Angiogenic Factors: In Vivo Analysis of Tumor-Stromal Interaction Yasuo Saijo, Masashi Tanaka, Makoto Miki, The Journal of Immunology	2002	247
The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer Kazuhiro Usui, Chiharu Tanai, Yoshiaki Tanaka, Respirology	2010	149
Gene transfer of thromboxane A(2) synthase and prostaglandin I(2) synthase antithetically altered tumor angiogenesis and tumor growth. Prasenohadi Pradono, Ryushi Tazawa, Makoto Maemondo, PubMed Tumor BiologyTumor AngiogenesisAngiogenesisCancer Cell BiologyAnti-cancer Agent	2002	119
Mouse SWAM1 and SWAM2 Are Antibacterial Proteins Composed of a Single Whey Acidic Protein Motif Koichi Hagiwara, Tohru Kikuchi, Yoshiyuki Endo, The Journal of Immunology	2003	117
Targeting Angiogenesis and HGF Function Using an Adenoviral Vector Expressing the HGF Antagonist NK4 for Cancer Therapy Makoto Maemondo, Ko Narumi, Yasuo Saijo, Molecular Therapy Tumor BiologyAngiogenesisAdenoviral VectorImmunologyTumor Immunity	2002	63
Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L) Ryoji Kato, Hidetoshi Hayashi, Yasutaka Chiba, Journal for ImmunoTherapy of Cancer	2020	61
A phase II study of bevacizumab with carboplatin-pemetrexed in non-squamous non-small cell lung carcinoma patients with malignant pleural effusions: North East Japan Study Group Trial NEJ013A Kazuhiro Usui, Shunichi Sugawara, Masaru Nishitsuji, Lung Cancer MedicineMalignant Pleural EffusionsImmunologyPathologyPhase Ii Study	2016	48
Atypical X-linked Agammaglobulinemia Diagnosed in Three Adults. S. Hashimoto, Toshio Miyawaki, Takeshi Futatani, Internal Medicine	1999	46
The Successful Treatment of Pulmonary Pleomorphic Carcinoma with Pembrolizumab: A Case Report Yōko Matsumoto, Tamaki Miura, Hajime Horiuchi, Case Reports in Oncology Health SciencesSuccessful TreatmentMedicineMultiple Pulmonary NodulePathology	2017	40

Page 1